F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model

References

• Seto E, Ooka T, Middeldorp J, Takada K. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res. 2008;68:1030–1036. doi:10.1158/0008-5472.CAN-07-525218281477
   PubMed Web of Science ®Google Scholar
• Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160270. doi:10.1098/rstb.2016.027028893937
   PubMed Web of Science ®Google Scholar
• Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol. 2012;22:79–86. doi:10.1016/j.semcancer.2011.12.01122245473
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Wakisaka N, Kondo S, et al. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Cancer Metastasis Rev. 2017;36:435–447. doi:10.1007/s10555-017-9693-x28819752
   PubMed Web of Science ®Google Scholar
• Shair KH, Schnegg CI, Raab-Traub N. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. Cancer Res. 2009;69:5734–5742. doi:10.1158/0008-5472.CAN-09-046819584275
   PubMed Web of Science ®Google Scholar
• Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32:54–73. doi:10.1053/j.semdp.2015.02.02125769204
   PubMed Web of Science ®Google Scholar
• Husaini R, Ahmad M, Soo-Beng Khoo A. Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway. BMC Res Notes. 2011;4:551–661. doi:10.1186/1756-0500-4-55122185663
   PubMedGoogle Scholar
• Correia S, Palser A, Elgueta Karstegl C, et al. Natural variation of Epstein-Barr virus genes, proteins, and primary MicroRNA. J Virol. 2017;91:e00375–e00317. doi:10.1128/JVI.00955-1728515295
   PubMed Web of Science ®Google Scholar
• Choi SJ, Jung SW, Huh S, et al. Phylogenetic comparison of Epstein-Barr virus genomes. J Microbiol. 2018;56:525–533. doi:10.1007/s12275-018-8039-x29948828
   PubMed Web of Science ®Google Scholar
• Turunen Aaro1 RJ, Reidar G. Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. oncotarget. 2017;8:27328–27338. doi:10.18632/oncotarget.1603328423694
   PubMedGoogle Scholar
• Zhang L, Hong K, Zhang J, et al. Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology. 2004;323:141–152. doi:10.1016/j.virol.2004.03.00715165826
   PubMed Web of Science ®Google Scholar
• Liu H, Zheng H, Duan Z, et al. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells. Mol Cancer. 2009;8:92–100. doi:10.1186/1476-4598-8-9219860880
   PubMed Web of Science ®Google Scholar
• Ting CM, Wong CK, Wong RN, et al. Role of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells. Mol Carcinog. 2012;51:963–972. doi:10.1002/mc.2086722006341
   PubMed Web of Science ®Google Scholar
• Li SS, Yang S, Wang S, et al. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway. Oncol Rep. 2011;26:1573–1579. doi:10.3892/or.2011.142321850380
   PubMed Web of Science ®Google Scholar
• Chung GT, Lou WP, Chow C, et al. Constitutive activation of distinct NF-kappaB signals in EBV-associated nasopharyngeal carcinoma. J Pathol. 2013;231:311–322. doi:10.1002/path.423923868181
   PubMed Web of Science ®Google Scholar
• Hu Q, Lin X, Ding L, et al. ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma. Cancer Med. 2018;7:3862–3874. doi:10.1002/cam4.155229936709
   PubMed Web of Science ®Google Scholar
• Wang Z, Luo F, Li L, et al. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer. 2010;46:2996–3006. doi:10.1016/j.ejca.2010.07.00820709526
   PubMed Web of Science ®Google Scholar
• Lu JH, Tang YL, Yu HB, et al. Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance. Lab Invest. 2010;90:196–209. doi:10.1038/labinvest.2009.13019997065
   PubMed Web of Science ®Google Scholar
• Yip YL, Lin W, Deng W, et al. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. Lab Invest. 2018;98:1093–1104. doi:10.1038/s41374-018-0034-729769697
   PubMed Web of Science ®Google Scholar
• Xiao K, Yu Z, Li X, et al. Genome-wide Analysis of Epstein-Barr Virus (EBV) integration and strain in C666-1 and Raji cells. J Cancer. 2016;7:214–224. doi:10.7150/jca.1315026819646
   PubMed Web of Science ®Google Scholar
• Ngan HL, Wang L, Lo KW, et al. Genomic landscapes of EBV-associated nasopharyngeal carcinoma vs. HPV-associated head and neck cancer. Cancers. 2018;10:210–230. doi:10.3390/cancers10070210
   PubMed Web of Science ®Google Scholar
• Tsang CM, Zhang G, Seto E, et al. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Int J Cancer. 2010;127:1570–1583. doi:10.1002/ijc.2517320091869
   PubMed Web of Science ®Google Scholar
• Mo AJ, Kurzeder C, Mautner J, et al. Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol. 2000;74:10142–10152. doi:10.1128/jvi.74.21.10142-10152.200011024143
   PubMed Web of Science ®Google Scholar
• Elgui de Oliveira D, Muller-Coan BG, Pagano JS. Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers. Trends Microbiol. 2016;24:649–664. doi:10.1016/j.tim.2016.03.00827068530
   PubMed Web of Science ®Google Scholar
• Cheung ST, Huang DP, Hui AB, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer. 1999;83(1):121–126. doi:10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F10449618
   PubMed Web of Science ®Google Scholar
• Lo AK, Lo KW, Tsao SW, et al. Epstein-Barr virus infection alters cellular signal cascadesin human nasopharyngeal epithelial cells. Neoplasia. 2006;8(3):173–180. doi:10.1593/neo.0562516611410
   PubMed Web of Science ®Google Scholar
• Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5:423–428.15144950
   PubMed Web of Science ®Google Scholar
• Tsang CM, Tsao SW. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Virol Sin. 2015;30(2):107–121. doi:10.1007/s12250-015-3592-525910483
   PubMed Web of Science ®Google Scholar
• Wu C, Peng S, Sun W, et al. Association of E-cadherin methylation with risk of nasopharyngeal cancer: a meta-analysis. Head Neck. 2018;40:2538–2545. doi:10.1002/hed.2531929947108
   PubMed Web of Science ®Google Scholar
• Tsao SW, Tramoutanis G, Dawson CW, et al. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12(6):473–487.12450733
   PubMed Web of Science ®Google Scholar
• Pathmanathan R, Prasad U, Sadler R, et al. Clonal proliferations of cells infected with Epstein–barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995;333:693–698. doi:10.1056/NEJM1995091433311037637746
   PubMed Web of Science ®Google Scholar
• Morris MA, Laverick L, Wei W, et al. The EBV-encoded oncoprotein, LMP1, induces an Epithelial-to-Mesenchymal Transition (EMT) via its CTAR1 domain through integrin-mediated ERK-MAPK Signalling. Cancers. 2018;10:130–156. doi:10.3390/cancers10050130
   PubMed Web of Science ®Google Scholar
• Chen H, Hutt-Fletcher L, Cao L, et al. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol. 2003;77:4139–4148. doi:10.1128/jvi.77.7.4139-4148.200312634372
   PubMed Web of Science ®Google Scholar
• Leeman RJ, Lui VW, Grandis JR. STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther. 2006;6:1471–2598. doi:10.1517/14712598.6.3.231
   Web of Science ®Google Scholar
• Tan YN, Tao YG, Song X, et al. Expression of JAK3 in nasopharyngeal carcinoma cell line associated with STAT activation regulated by EB virus encoded protein LMP1. Prog Biochem Biophys. 2003;30:560–565.
   Web of Science ®Google Scholar
• Dawson CW, Tramountanis G, Eliopoulos AG, et al. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem. 2003;278:3694–3704. doi:10.1074/jbc.M20984020012446712
   PubMed Web of Science ®Google Scholar
• Hammarskjold ML, Simurda MC. Epstein–Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J Virol. 1992;66:6496–6501.1404600
   PubMed Web of Science ®Google Scholar